Reuben Richards

Chief Exective Officer and Board of Directors

Former Chairman Emeritus, Chairman and CEO of Emcore (NASDAQ:EMKR). Mr. Richards was Senior Managing Director of Jesup & Lamont Capital Markets Inc., a Principal with Hauser, Richards & Co., and a Director of Prudential-Bache Capital Funding in its Investment Banking Division. He serves as a Director of Qusion Technologies, Inc. Mr. Richards also serves on the Board of Emcore Corp.'s Gelcor LLC Joint Venture, and is a Director of SA Telecommunications, Inc. 

Paul Cate

Chairman of the Board of Directors

Chief Executive Officer at Mark IV Capital, Inc. With over twenty-five years of executive experience in the real estate development and financial services fields, Mr. Cate has guided Mark IV Capital since 1998 setting the strategic direction and actively managing the execution of specific corporate goals.

Jack Van Berkel

Member, Board of Directors

Founder and Managing Principal, CA Capital Representatives and CA Capital CRE, primarily focused on developing and strengthening relationships across the real estate and technology markets. Mr. Van Berkel has more than 25 years of experience in the areas of corporate strategy, executive management, organization development, human capital, compensation, and capital markets. Earlier in his career, he held senior management positions with First Data Corporation, Gateway Corporation and Western Digital.

Jack Syage

Member, Board of Directors

CEO and Co-Founder of ImmunogenX, a biopharmaceutical company focused on therapeutic and diagnostic solutions for celiac disease. Dr. Syage has over 25 years of experience creating and leading the development of innovative technologies in the analytical instrumentation field. He is regarded as a leading expert in mass spectrometry and trace chemical detection. Previously he founded Syagen Technology, Inc. and led its growth culminating in the successful acquisition in 2011 by the $20B/yr French company Safran. Jack also sits on the Board of Directors of Advanced Telesensors, Flamentera AG, Analytical Detection, and Appellation Ventures. Jack has published over 130 papers, delivered over 80 invited talks, has over 30 U.S. patents issued or pending, and appears on the list of the Most Highly Cited Chemists. His honorary positions included Visiting Professor at UC Irvine, Visiting Professor at the Université de Paris-Sud, Editorial Board member of the Journal of Physical Chemistry, and invitee to the Nobel Symposium in Chemistry. He received BA and PhD degrees from Hamilton College and Brown University, respectively, where he won several academic awards including Best Thesis. He was a postdoctoral fellow at Caltech under Nobel Laureate Ahmed Zewail.

Gregory Weiss, Ph.D.

Co-founder and Member, Board of Directors

Professor of Chemistry, Pharmaceutical Sciences, Molecular Biology, and Biochemistry at the University of California, Irvine. Dr. Weiss trained at Genentech, Harvard, and UC Berkeley before joining the faculty at UCI in 2000. His laboratory focuses on the interface between chemistry and biology, including the study of membrane proteins and bioelectronics. His awards include Beckman Foundation Young Investigator, election to Fellow of the American Association for the Advancement of Science (AAAS), and an Ig Nobel Prize in Chemistry for leading the team that “partially unboiled the egg.” He has co-authored >95 publications, co-invented >10 patents, and has presented >200 invited seminars. Dr. Weiss co-invented PhageTech’s core technology with Dr. Penner.

Richard Henson

Co-founder and Member, Board of Directors

Mr. Henson has over 30 years of experience in medical device development and manufacturing.  He has also served on the boards of Halo Healthcare, a breast cancer diagnostic company; ResVeRx, Inc., a nutraceutical manufacturer; and TWAComm, a telecommunications company.  He is also Co-Chairman of Octane Foundation and a board member of OCTANe as well as a former member of the Chancellor’s CEO Roundtable at UC Irvine.  

Reginald Penner, Ph.D.


Chancellor’s Professor in the Department of Chemistry at the University of California, Irvine.  Professor Penner attended Gustavus Adolphus College in Saint Peter, Minnesota where he obtained B.A. degrees in Chemistry and Biology in 1983.  He studied at Texas A&M University beginning in 1983 with Professor Charles R. Martin, and received a Ph.D. in Chemistry in 1987.  After postdoctoral studies at Stanford University and Caltech working with Professor Nate Lewis, he joined UCI in 1990.  Professor Penner is an electrochemist whose research group develops methods based upon electrodeposition for making nanomaterials, such as nanowires, composed of metals and semiconductors.  With his students, he has published >170 research papers. He is an A.P. Sloan Fellow, a Camille and Henry Dreyfus Teacher-Scholar, an NSF and ONR Young Investigator, and a Fellow of the American Association for the Advancement of Science (AAAS).  He received the 2009 Faraday Medal from the Royal Society of Chemistry of the UK, the 2016 Charles N. Reilley Award from the Society for Electroanalytical Chemistry, and the 2016 Division of Analytical Chemistry Award in Electrochemistry.  Professor Penner is Associate Editor at ACS Nano.Dr. Penner co-invented PhageTech’s core technology with Dr. Weiss.

Please reload

© 2020 PhageTech, Inc.     All rights reserved

Screen Shot 2017-07-13 at 2.07.46 PM.png